Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4190)
All Articles published online
|
Aug 6, 2012 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
De Francesco V, Ierardi E, Hassan C, Zullo A. |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v3/i4/68.htm |
| Number | Citing Articles |
| 1 |
Nasrullah Jan, Asadullah Madni, Safiullah Khan, Hassan Shah, Faizan Akram, Arshad Khan, Derya Ertas, Mohammad F. Bostanudin, Christopher H. Contag, Nureddin Ashammakhi, Yavuz Nuri Ertas. Biomimetic cell membrane‐coated poly(lactic‐co‐glycolic acid) nanoparticles for biomedical applications. Bioengineering & Translational Medicine 2023; 8(2) doi: 10.1002/btm2.10441
|
| 2 |
Omid Tadjrobehk, Hamid Abdollahi. Reduction in Mutation Frequency of Clarithromycin Resistance by Extracts from Three Iranian Herbs in Helicobacter pylori Isolates. American Journal of Drug Discovery and Development 2013; 3(3): 174 doi: 10.3923/ajdd.2013.174.180
|
| 3 |
P Malfertheiner, F Megraud, C A O'Morain, J P Gisbert, E J Kuipers, A T Axon, F Bazzoli, A Gasbarrini, J Atherton, D Y Graham, R Hunt, P Moayyedi, T Rokkas, M Rugge, M Selgrad, S Suerbaum, K Sugano, E M El-Omar. Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report. Gut 2017; 66(1): 6 doi: 10.1136/gutjnl-2016-312288
|
| 4 |
Amin Talebi Bezmin Abadi. Helicobacter pylori treatment: New perspectives using current experience. Journal of Global Antimicrobial Resistance 2017; 8: 123 doi: 10.1016/j.jgar.2016.11.008
|
| 5 |
Giulia Fiorini, Angelo Zullo, Nimish Vakil, Ilaria M. Saracino, Chiara Ricci, Valentina Castelli, Luigi Gatta, Dino Vaira. Rifabutin Triple Therapy is Effective in Patients With Multidrug-resistant Strains of Helicobacter pylori. Journal of Clinical Gastroenterology 2018; 52(2): 137 doi: 10.1097/MCG.0000000000000540
|
| 6 |
Chun-Hua Wang, Sheng-Tao Liao, Jun Yang, Chun-Xia Li, Ying-Ying Yang, Ran Han, Dong-Feng Chen, Chun-Hui Lan. Effects of daily telephone-based re-education before taking medicine on <italic>Helicobacter pylori</italic> eradication: A prospective single-center study from China. World Journal of Gastroenterology 2015; 21(39): 11179-11184 doi: 10.3748/wjg.v21.i39.11179
|
| 7 |
Katayoun Borhani, Ashraf Mohabati Mobarez, Ali Reza Khabiri, Mehrdad Behmanesh, Nima Khoramabadi. Inhibitory effects of rHP-NAP IgY against Helicobacter pylori attachment to AGS cell line. Microbial Pathogenesis 2016; 97: 231 doi: 10.1016/j.micpath.2016.06.004
|
| 8 |
Emad M. Eed, Yousry A. Hawash, Amany S. Khalifa, Khalaf F. Alsharif, Saleh A. Alghamdi, Taisir Saber, Khadiga A. Ismail, Somaia A. Shehab‐Eldeen. Molecular diagnosis of Helicobacter pylori antibiotic resistance in the Taif region, Saudi Arabia. Microbiology and Immunology 2019; 63(6): 199 doi: 10.1111/1348-0421.12686
|
| 9 |
Fernando Macías‐García, José Llovo‐Taboada, Mario Díaz‐López, Iria Bastón‐Rey, Juan Enrique Domínguez‐Muñoz. High primary antibiotic resistance of Helicobacter Pylori strains isolated from dyspeptic patients: A prevalence cross‐sectional study in Spain. Helicobacter 2017; 22(6) doi: 10.1111/hel.12440
|
| 10 |
Aimi Hanafi, Woon Ching Lee, Mun Fai Loke, Xinsheng Teh, Ain Shaari, Mojdeh Dinarvand, Philippe Lehours, Francis Mégraud, Alex Hwong Ruey Leow, Jamuna Vadivelu, Khean Lee Goh. Molecular and Proteomic Analysis of Levofloxacin and Metronidazole Resistant Helicobacter pylori. Frontiers in Microbiology 2016; 7 doi: 10.3389/fmicb.2016.02015
|
| 11 |
|
| 12 |
|
| 13 |
Kuifeng Wang, Min Zhu, Yongzhi Tang, Junyan Liu, Fei Yan, Zhenjun Yu, Jiansheng Zhu. Integration of virtual screening and susceptibility test to discover active-site subpocket-specific biogenic inhibitors of Helicobacter pylori shikimate dehydrogenase. International Microbiology 2019; 22(1): 69 doi: 10.1007/s10123-018-0029-7
|
| 14 |
Savita Yadav, Subramanian Karthikeyan. Structural and biochemical characterization of GTP cyclohydrolase II from Helicobacter pylori reveals its redox dependent catalytic activity. Journal of Structural Biology 2015; 192(1): 100 doi: 10.1016/j.jsb.2015.08.004
|
| 15 |
Hriday Bera, Sabyasachi Maiti, Sudipta Saha, Amit Kumar Nayak. Polysaccharide Carriers for Drug Delivery. 2019; : 713 doi: 10.1016/B978-0-08-102553-6.00024-6
|
| 16 |
G. Losurdo, G. Leandro, M. Principi, F. Giorgio, L. Montenegro, C. Sorrentino, E. Ierardi, A. Di Leo. Sequential vs. prolonged 14-day triple therapy forHelicobacter pylorieradication: the meta-analysis may be influenced by ‘geographical weighting’. International Journal of Clinical Practice 2015; 69(10): 1112 doi: 10.1111/ijcp.12687
|
| 17 |
Yue-Xi Zhang, Li-Ya Zhou, Zhi-Qiang Song, Jian-Zhong Zhang, Li-Hua He, Yu Ding. Primary antibiotic resistance of <italic>Helicobacter pylori</italic> strains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study. World Journal of Gastroenterology 2015; 21(9): 2786-2792 doi: 10.3748/wjg.v21.i9.2786
|
| 18 |
Johnny Lisboa, Louisa Celma, Dyana Sanchez, Mathilde Marquis, Jessica Andreani, Raphael Guérois, Françoise Ochsenbein, Dominique Durand, Stéphanie Marsin, Philippe Cuniasse, J. Pablo Radicella, Sophie Quevillon‐Cheruel. The C‐terminal domain of HpDprA is a DNA‐binding winged helix domain that does not bind double‐stranded DNA. The FEBS Journal 2019; 286(10): 1941 doi: 10.1111/febs.14788
|
| 19 |
Başak Çakır Güney, Tolga Düzenli, Yeşim Önal, Mustafa Kaplan, Alpaslan Tanoğlu. Favorable effects of close telephone follow-up on Helicobacter pylori eradication success. Anatolian Current Medical Journal 2021; 3(1): 10 doi: 10.38053/acmj.865053
|
| 20 |
Seham S. El-seid, Fatma A. Attia, Mona Abd El-Raouf, Ghada S. Abd Al-Azeem, Nagwa Abd EL-Ghaffar Mohammed, Heba Anwar. The role of Helicobacter pylori in minimal hepatic encephalopathy. The Egyptian Journal of Internal Medicine 2015; 27(1): 26 doi: 10.4103/1110-7782.155849
|
| 21 |
Sukhbir K Shahid.
Novel Anti
-Helicobacter Pylori
Therapies
. Pharmaceutical Patent Analyst 2014; 3(4): 411 doi: 10.4155/ppa.14.27
|
| 22 |
Yuri L. Fedorchenko, Marina V. Martynuk. Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders. Diabetes mellitus 2018; 20(6): 427 doi: 10.14341/DM8689
|
| 23 |
|
| 24 |
Anurag Verma, Juhi Dubey, Rahul Rama Hegde, Vaibhav Rastogi, J. K. Pandit. Helicobacter pylori: past, current and future treatment strategies with gastroretentive drug delivery systems. Journal of Drug Targeting 2016; 24(10): 897 doi: 10.3109/1061186X.2016.1171326
|
| 25 |
Zhiqiang Song, Jianzhong Zhang, Lihua He, Minhu Chen, Xiaohua Hou, Zhaoshen Li, Liya Zhou. Prospective multi-region study on primary antibiotic resistance of Helicobacter pylori strains isolated from Chinese patients. Digestive and Liver Disease 2014; 46(12): 1077 doi: 10.1016/j.dld.2014.08.038
|
| 26 |
A. Boukir, I. Azghari, I. El Ghissassi, H. Errihani. Lymphome de MALT gastrique : rôle de l’Helicobacter pylori et sa place dans la prise en charge. Journal Africain d'Hépato-Gastroentérologie 2015; 9(3): 119 doi: 10.1007/s12157-015-0605-9
|
| 27 |
Ju Yup Lee. Why Is Regional Helicobacter pylori Eradication Treatment Report Important?. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2022; 22(2): 83 doi: 10.7704/kjhugr.2022.0018
|
| 28 |
Angelo Zullo, Giuseppe Scaccianoce, Vincenzo De Francesco, Valentina Ruggiero, Pasquale D’Ambrosio, Luigi Castorani, Leonilde Bonfrate, Lucy Vannella, Cesare Hassan, Piero Portincasa. Concomitant, sequential, and hybrid therapy for H. pylori eradication: A pilot study. Clinics and Research in Hepatology and Gastroenterology 2013; 37(6): 647 doi: 10.1016/j.clinre.2013.04.003
|
| 29 |
I V Maev, D N Andreev. Molecular genetic predictors of resistance to anti-Helicobacter pylori therapy. Terapevticheskii arkhiv 2017; 89(8): 5 doi: 10.17116/terarkh20178985-12
|
| 30 |
Trung Nam Phan, Antonella Santona, Van Huy Tran, Thi Nhu Hoa Tran, Van An Le, Pietro Cappuccinelli, Salvatore Rubino, Bianca Paglietti. High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam. International Journal of Antimicrobial Agents 2015; 45(3): 244 doi: 10.1016/j.ijantimicag.2014.10.019
|
| 31 |
|
| 32 |
Vincenzo De Francesco, Cesare Hassan, Lorenzo Ridola, Floriana Giorgio, Enzo Ierardi, Angelo Zullo. Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study.
Journal of Medical Microbiology
2014; 63(5): 748 doi: 10.1099/jmm.0.072322-0
|
| 33 |
C. S. Pitchumoni, Abhijeet Chaubal, Gopal Desai. Geriatric Gastroenterology. 2021; : 1881 doi: 10.1007/978-3-030-30192-7_117
|
| 34 |
Moumita Saha, Ashutosh Gupta, Shiran Shetty, Srinivas Mutalik, K. Nandakumar, H. Raghu Chandrashekar, Namdev Dhas, Sudheer Moorkoth. DoE-Aided Optimization of RP-HPLC Method for Simultaneous Estimation of Amoxicillin and Tinidazole Loaded Mucoadhesive GRDDS Formulation for the Treatment of H. pylori. Chromatographia 2024; 87(9): 533 doi: 10.1007/s10337-024-04346-8
|
| 35 |
Maliheh Safavi, Reyhaneh Sabourian, Alireza Foroumadi. Treatment of <i>Helicobacter pylori</i> infection: Current and future insights. World Journal of Clinical Cases 2016; 4(1): 5-19 doi: 10.12998/wjcc.v4.i1.5
|
| 36 |
Yan Zhao, Mudan Ren, Xin Wang, Guifang Lu, Xinlan Lu, Dan Zhang, Shuixiang He. Telephone-Based Reeducation of Drug Administration for Helicobacterpylori Eradication: A Multicenter Randomized Controlled Study. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/8972473
|
| 37 |
Nuno Almeida, José M. Romãozinho, Maria M. Donato, Cristina Luxo, Olga Cardoso, Maria A. Cipriano, Carol Marinho, Carlos Sofia. Triple Therapy with High‐Dose Proton‐Pump Inhibitor, Amoxicillin, and Doxycycline Is Useless for Helicobacter pylori Eradication: A Proof‐of‐Concept Study. Helicobacter 2014; 19(2): 90 doi: 10.1111/hel.12106
|